Dan Wilmer, Executive Vice President and Chief Product Officer, InStep Health
Dan Wilmer, Executive Vice President and Chief Product Officer, InStep Health talks about the positive impact that digital tools and solutions are having on patients with Taren Grom from PharmaVOICE.
Brigham Hyde, President, Data & Analytics, EVERSANA
Brigham Hyde, President, Data & Analytics, EVERSANA talks about supporting organizations to adapt to an evolving digital transformation with Taren Grom from PharmaVOICE.
Kathleen Mandziuk, MPH, RN, Vice President of Digital Health, PRA Health Sciences
Kathleen Mandziuk, MPH, RN, PRA Health Sciences, talks about a data-led 360º patient view and data-driven decision-making with Taren Grom from PharmaVOICE. Other videos in the series: Part 2: Better Patient Journey Part 3: Clinical Research Simplified
Christina Fawcett, Senior Director of Operations in Real World Solutions, Digital Health, PRA Health Sciences
Christina Fawcett, PRA Health Sciences, talks about patient-centric trial design and creating a better overall patient journey pathway with Taren Grom from PharmaVOICE. Other videos in the series: Part 1: A Data Led Approach Part 3: Clinical Research Simplified
Marcus Grindstaff, Senior Vice President, Connected Health, PRA Health Sciences
Marcus Grindstaff, PRA Health Sciences, talks about integrating fit-for-purpose technology into the trial to simplify clinical research with Taren Grom from PharmaVOICE. Other videos in the series: Part 1: A Data Led Approach Part 2: Better Patient Journey
Dinesh Kasthuril, Head of Global Client Relations & Project Management, Patient Safety Solutions, Covance
Dinesh Kasthuril, Covance, talks about pharmacovigilance and the future of safety data and the role of technology with Taren Grom from PharmaVOICE.
J.P. Maranzani, VP, Account Group Supervisor - Point of Care Practice (EHR/ABM), Ogilvy Health
J.P. Maranzani, Ogilvy Health, talks about ways in which marketers can use AI to make brands more successful with Taren Grom from PharmaVOICE.
Roshawn Blunt, Managing Director, 1798, a Fingerpaint company
Roshawn Blunt, 1798, a Fingerpaint company, talks about the unique commercialization challenges gene and cell therapy companies face with Taren Grom from PharmaVOICE.
Bryan O'Malley & Nick Bartolomeo, co-leads of Fingerpaint’s Shift Performance Center of Excellence
Bryan O’Malley & Nick Bartolomeo, co-leads of Fingerpaint’s Shift Performance Center of Excellence, talk about the influence of data on healthcare marketing with Taren Grom from PharmaVOICE.
Malai Sankarasubbu, Vice President, Artificial Intelligence Research, Saama Technologies
Malai Sankarasubbu, Saama Technologies, talks about optimizing AI to improve clinical trials with Taren Grom from PharmaVOICE.
Rich Christie, M.D., Ph.D., Chief Development Officer, AiCure
Rich Christie, M.D., Ph.D., AiCure, talks about the adoption of technology to improve the clinical trial process with Taren Grom from PharmaVOICE.
Maria Kirsch, Senior Vice President, Head of Patient Services Operations, EVERSANA
Maria Kirsch, EVERSANA, talks about the biggest trends in patient services with Taren Grom from PharmaVOICE.
Matthew Van Wingerden, GM, Advanced Services, Aktana
Matthew Van Wingerden, Aktana, talks about using AI effectively to solve major challenges with Taren Grom from PharmaVOICE.
Claire Bonaci, Sr. Director, US Health and Life Sciences, Microsoft
Claire Bonaci, Microsoft, talks about how AI collaborations are transforming the life-sciences industry with Taren Grom from PharmaVOICE.
Max Divak, Interactive Group Supervisor, Ogilvy Health
Max Divak, Ogilvy Health, talks about the ways AI can be used to augment brand/company messaging with Taren Grom from PharmaVOICE.
Amrita Bhowmick, Chief Community Officer, Health Union
Amrita Bhowmick, Health Union, talks about ways to leverage social media to help combat social isolation with Taren Grom from PharmaVOICE.
Gregory Skalicky, EVERSANA
Gregory Skalicky, EVERSANA, talks about commercial support for small to mid-tier innovative companies with Taren Grom from PharmaVOICE.
Gregory T. Simpson, VP and Head of Marketing, Saama Technologies
Gregory T. Simpson, VP and Head of Marketing, Saama Technologies, talks to the importance of remote monitoring to improve a clinical trial and accelerate outcomes and what sponsors need to consider when looking for a remote monitoring program.
Richard Gliklich, M.D., CEO, OM1
Richard Gliklich, M.D., CEO, OM1, discusses the special considerations and challenges around quality in clinical data in terms of regulatory considerations as well as how AI and machine learning factor into R&D today and in the future.
Chris Benko, CEO, Koneksa
Chris Benko, CEO, Koneksa, speaks to the current regulatory climate surrounding digital biomarkers and illustrates the potential of this technology.
MaryAnne Rizk, Ph.D., Senior VP, Digital R&D Strategy, IQVIA R&D Solutions
MaryAnne Rizk, Ph.D., Senior VP, Digital R&D Strategy, IQVIA, examines how increased virtuality and digitization will lead to a new era of patient care and how making clinical development part of patient care can change the trajectory of health outcomes.
Erica Prowisor, Global Head, Recruitment & Retention, IQVIA
Erica Prowisor, Global Head, Recruitment & Retention, IQVIA, explores the impact of COVD-19 on patient recruitment and what the future holds in terms of a more holistic human-centered approach to recruiting.
Elisa Cascade, Executive VP of eCOA, ERT
Elisa Cascade, Executive VP of eCOA, ERT, talks about the impact that COVID-19 is having on clinical trial data collection and the technical advances ERT offers to help facilitate remote data capture to keep clinical trials on track.
Raj Indupuri, CEO, eClinical Solutions
Raj Indupuri, CEO, eClinical Solutions, previews his 2020 DIA session addressing the key uses of AI in the data review process as well as how AI can transform data management.
Andrew Schachter, CEO & Founder, Axiom Real-Time Metrics Inc.
Andrew Schachter, CEO and Founder, Axiom Real-Time Metrics Inc., outlines the importance of a unified platform to the success of clinical trials in today’s environment.
Jason Casarella, Executive VP, Business Development & Marketing, Advanced Clinical
Jason Casarella, Executive VP, Business Development & Marketing, Advanced Clinical, discusses the opportunities to improve clinical research presented by the global pandemic and what a return to “normal” might look like.
Michael O'Gorman, CEO & Founder, Life Science Marketplace
Michael O’Gorman, CEO & Founder, Life Science Marketplace, discusses industry trends impacting clinical trials amid the COVID-19 pandemic.
Jill Johnston, President, Study Planning and Site Optimization Division, WCG
In this Editor’s Take Video, Dan Limbach, producer of the PharmaVOICE Webcast Network, meets with WCG’s Jill Johnston to talk about the optimum clinical trial site activation process, overcoming the key challenges to getting there, and empowering the team responsible for thi … Read More »
Larissa Comis, Product Lead, Shared Investigator Platform, Cognizant
In this Editor’s Take Video, Dan Limbach, producer of the PharmaVOICE Webcast Network, meets with Larissa Comis to talk about Cognizant’s Shared Investigator Platform in its current form, and how it will look in the future, at the 2020 SCOPE Conference.
Nagaraja Srivatsan, Vice President and Chief Digital Officer, R&DS Technology Solutions, IQVIA
In this Editor’s Take Video, Dan Limbach, producer of the PharmaVOICE Webcast Network, meets with Nagaraja Srivatsan to talk about the role of the chief digital officer in life-sciences companies, IQVIA’s current and next-generation clinical stack, and how this technology de … Read More »
Andy Greenberg, Global Digital Lead for Life Sciences, Accenture
In this Editor’s Take Video, Dan Limbach, producer of the PharmaVOICE Webcast Network, meets with Andy Greenberg to talk about changing client needs in the liife-sciences industry, as well as the primary obstacles to broader adoption of digital technologies in clinical trial … Read More »
Tyler Pugsley, VP, Life Sciences, Medable
In this Editor’s Take Video, Dan Limbach, producer of the PharmaVOICE Webcast Network, meets with Tyler Pugsley to talk about Medable’s Patient Advisory Council, and why it is so important to involve patients earlier in the R&D process, at the 2020 SCOPE Conference.
Michelle Marlborough, Chief Product Officer, AiCure
Lauren Sunshine, Associate Director, AiCure
In this Editor’s Take Video, Dan Limbach, producer of the PharmaVOICE Webcast Network, meets with AiCure’s Michelle Marlborough and Lauren Sunshine to talk about how AI can improve clinical trials success rates, increase patient engagement, improve clinical outcomes, and boo … Read More »
Jason Zemcik, Senior Director, Products, TrialCard
Rick Fry, Senior Vice President, Market Solutions, TrialCard
In this Editor’s Take video, Taren Grom, Editor of PharmaVOICE, is at the 2019 World Congress Copay Summit in Alexandria, Virginia. She meets with Jason Zemcik and Rick Fry from TrialCard to talk about managing risk and mitigating fraud within copay support programs.
Paul LeVine, VP of Business Partnerships, Business Analytics, Mango Health, a TrialCard company
In this Editor’s Take video, Taren Grom, Editor of PharmaVOICE, is at the 2019 World Congress Copay Summit in Alexandria, Virginia. She meets with Paul LeVine, representing Mango Health, a TrialCard company. They talk about copay programs and their importance to a brand’s ma … Read More »
Mark Miller, Managing Director, Life Science Advertising, Marketing, and Commerce, at Deloitte Consulting
Mark Miller talks about how marketing and technology are partnering to improve human experiences, and how Customer Experience (CX) Centers of Excellence (COE) are driving these advancements.
David Shronk, Senior VP, Media, at Health Union
David Shronk describes how online health communities can improve the patient experience and deliver value to pharmaceutical companies.
Bryan O'Malley, Digital, at Fingerpaint
Bryan O’Malley discusses using digital tools for improving the brand experience, integrating the patient experience within a digital marketing strategy, and when to incorporate digital into the creative process in marketing.
Jason Casarella, EVP Business Development & Marketing, Advanced Clinical
Jason Casarella imagines an R&D ecosystem where barriers and labels were eliminated and we could all work together as one community. He also shares the importance of learning every day, and how even failure in clinical research provides valuable information and knowledge … Read More »
Peyton Howell, Chief Commercial and Strategy Officer, Parexel
Peyton Howell talks about what it would be like if we focused on bringing new treatments to patients using new, daring, and bold ideas. Filmed at the 2019 DIA Annual Conference in San Diego, CA.
Craig Lipset, former Head of Clinical Innovation at Pfizer
Craig Lipset discusses his career highlights working on the clinical research service provider side as well as within large pharma, and how the industry can evolve and raise the bar in clinical research using new technologies and processes. Filmed at the 2019 DIA Annual Conf … Read More »
Sheila Mahoney-Jewels, CEO & Co-Founder, LifeSciHub
Sheila Mahoney-Jewels discusses her “Imagine if” scenario about a single place to find the right independent consultant who can be onboarded immediately for a specific amount of time over the course of a project. Filmed at the 2019 DIA Annual Conference in San Diego, CA.
Bruce Hellman, CEO & Co-Founder, uMotif
Bruce Hellman imagines what would be possible if every person was a happily engaged research participant. Filmed at the 2019 DIA Annual Conference in San Diego, CA.
Andrew Schachter, CEO and Founder, Axiom Real-Time Metrics
Andrew Schachter explains how sponsors can us technology to achieve trial objectives more quickly and easily even as clinical research becomes increasingly complex and as FDA regulations demand more accountability.
Marc Hoffman, Chief Medical Officer, Celerion
Steve Clemons, Founder, VP of Clinical Operations, Vitalink Research
Marc Hoffman and Steve Clemons discuss the prevalence of COPD as the third-leading cause of death and how their two companies are collaborating to bring new biomarkers to sponsors and CROs to address this health crisis.
Tanya du Plessis, Vice President, Data Strategies and Solutions, Bioforum
Tanya du Plessis discusses why the increased adoption of new solutions, including medical and consumer-grade technologies, changed data collection / management processes and the role of data managers.
MaryAnne Rizk, Ph.D., Senior Vice President, Digital R&D Strategy, IQVIA
Dr. MaryAnne Rizk discusses one of the hottest topics of the moment: the digital transformation of R&D. She explains how an end-to-end patient-centric cloud platform can provide the needed orchestration.
Joel Selzer, Co-Founder and CEO, ArcheMedX
Joel Selzer discusses his company’s unique approach to measuring and analyzing behavioral insights from clinicians based on their interactions with educational and training content.
Eleanore Doyle, Executive Vice President, FSP 360, Syneos Health
Eleanor Doyle talks about the evolution of FSP (functional service outsourcing) and how Syneos Health’s FSP 360 model is driving speed, quality, and efficiencies for customers.
Joe Ehrline, Vice President of Sales, Saama
Joe Ehrline talks about the opportunities and benefits that life-science companies can gain by effectively employing data analytics as part of a comprehensive strategy to accelerate drug development.
Bruce Palsulich, Global VP of Product Strategy, Oracle
Bruce Palsulich discusses the impact AI will have on pharmacovigilance as well as other aspects of clinical trials and the industry at large.
Josh Rose, VP, Strategic Planning, IQVIA
Josh Rose discusses the coming of age of virtual trials and what sponsors need to know as they strategically evaluate this clinical model.
Donald A. Deieso, Ph.D., Executive Chairman & CEO, WCG
Mary Elizabeth Williams, Journalist and Author, "A Series of Catastrophes & Miracles: A True Story of Love, Science, and Cancer
Dr. Deieso and Ms. Williams discuss patient centricity in clinical development and ways to improve the patient experience.
Wenda Brennan, V.P., Global Pharmacovigilance, UBC
Wenda Brennan discusses important areas in adverse event reporting, and trends in pharmacovigilance.
Cat Hall, VP Product Strategy, endpoint
Cat Hall discusses the next priorities for technology advancement in helping to manage clinical trials and what future customer needs will need to be met.
Raj Induri, CEO, eClinical Solutions
Raj Indupuri of eClinical Solutions talks about the need for companies to transform their processes and adopt digital clinical capabilities and how to overcome current obstacles to achieve better outcomes.
Karin Beckstrom, Senior Product Manager, ERT
Karin Beckstrom discusses the opportunities that virtual trials can bring to the clinical trial ecosystem and to patients as well.
Mike Nolte, CEO, Signant Health
Mike Nolte talks about Signant’s new brand and the importance of bringing empathy into clinical trials.
Evgenia Mikhalchuk, Director, Business Development & Marketing, Flex Databases
Yvonne Lungershausen, CEO, Avance Clinical
Evgenia Mikhalchuk and Yvonne Lungershausen discuss the best practices for selecting the right clinical software provider and the benefits that a solid partnership provide to both entities.
Jason Casarella, Executive V.P., Business Development & Marketing, Advanced Clinical
Jason Casarella talks about why it’s important for companies to embrace E6 (R2), which provides a unified standard for the European Union, Japan, and the United States to facilitate the mutual acceptance of clinical data by the regulatory authorities in these jurisdictions.
Larissa Comis, Product Lead, Shared Investigator Platform, Cognizant
Larissa Comis discusses How Cognizant Shared Investigator Platform is reducing the administrative burden on sites and why organizational change management is so important for success.
Michelle Longmire, M.D., CEO, Medable
Dr. Michelle Longmire, CEO of Medable, talks about the value of eCOA and why it’s important to integrate data to improve the patient experience as part of participating in a clinical trial.
Matt Giegerich, CEO, The Inception Company
Shaun Urban, President, The Inception Company
Executives reflect on the major shifts in the industry in the last 15 years and the evolving market dynamics that will impact global communication. You may also read the Executive Perspective article in the March issue of PharmaVOICE, using the link below.